174 medicines not purchased by hospitals (with list)

Many well-known varieties, application for scrap of the bid, withdrawal of thetoday (November 4), Ningxia Hui Autonomous Region Public Resources Trading Network announced the "proposed cancellation of some production enterprises drug winning bid (hanging network) qualification notice" (hereinafter referred to as "Notice")notice shows that, after the study decision, agreed to 71 enterprises to apply for the invalid bid of the drug (revoking the network), to cancel the above-listed enterprise drug winning bid (hanging network) qualificationThe public notice period is from November 4 to November 8, 2019, and if there is any objection during the publicity period, the enterprise is requested to issue a power of attorney and official documents to submit a complaint to the Medical Tender and Procurement Section of the Centerit is understood that Hunan Qianjin Xiangjiang Pharmaceutical's Montita, Fusen Pharmaceutical's double yellow even oral liquid, Guangzhou Baiyunshan Tianxin Pharmaceutical's cephalosporine tablets and Chenxin Pharmaceutical's injection of triphosphate cytosine disodium and other 8 products, apply for waste bidin addition,, Ma Yinglong Pharmaceutical's musk saffron paste, compound licorice oral solution, Chongqing drug friend's altoily ols, China Resources Seiko's hydrochloric acid trax tablets and other 166 products apply to cancel the networkcombined with a total of 174 products, exiting Ningxia's hospital marketcan not guarantee the supply, the pain of pharmaceutical companiesalthough Ningxia involved in the drug market share is not much, but in recent years it has been actively announcing the drug's online adjustmentit is understood that if pharmaceutical companies are not suspected of violations, such as because of drug quality problems were notified, pharmaceutical companies were recovered GMP certificate, quotation dishonesty and other reasons were asked to withdraw off the network, pharmaceutical companies take the initiative to withdraw drugs, often and drug costs rise, and the price of the internet is lowerIn addition, if the local drug market is relatively small, drug companies will be more willing to withdraw from the networkespecially after entering the bidding season, enterprise products or will face the pressure of national price linkage, in order to avoid price linkage affecting the winning prices in other provinces, enterprises will choose to withdraw the net, give up the market price of the low-lying landon the other hand, the product after winning the bid enterprise can not supply the phenomenon also occurs from time to time, and many provinces and cities clearly can not normal supply of pharmaceutical enterprises to punish - light scrap bid, cancel the winning bid qualification, deduct the performance bond, heavy into the bad record, cancel all products of the enterprise in the province's winning bid qualificationit is worth noting that in Ningxia to apply for the cancellation of the list of drugs, there are 59 traditional Chinese medicine, 105 chemicals and biological productson traditional Chinese medicine, as the main raw materials of traditional Chinese medicine, the price of Traditional Chinese medicine has been maintained at a relatively high level, which is an important cost burden for pharmaceutical companies, at the same time, labor, packaging materials, production hardware and other costs have been increasing, and Chinese traditional medicine enterprise pricing has a certain lag effect, the enterprise's drug price is difficult to maintain, so choose the initiative to take the initiative Abandoned products for some chemicals and biological products, many pharmaceutical production of raw materials, environmental protection, manpower and other costs in the year-on-year increase, but the tender instead needs to reduce prices, drug companies bring a lot of pressure; because of the failure to supply and be included in the bad record, pharmaceutical companies have to pay a huge price, in order to reduce the loss to an acceptable range, they voluntarily withdraw from Ningxia's hospital market, which is also reasonable Ningxia to cancel the list of drugs eligible for winning the bid (hanging the net)